This study identifies Tip60 as a regulator of GBM invasiveness, demonstrating its role in downregulating MT1-MMP expression and cell adhesion through NF-κB suppression, thus highlighting Tip60 as a potential therapeutic target [127]. Here, KAT5 is linked to glioblastoma.